Comply and Optimize
According to the Health Resources and Services Administration (HRSA), enrolled hospitals and other covered entities can achieve average savings of 25 to 50% in pharmaceutical purchases.
As regulatory scrutiny over the 340B Program has recently been intensified by HRSA, covered entities must utilize independent audits as part of fulfilling their ongoing obligation to ensure compliance. Microscope’s experienced team and compliance services allow covered entities to reinforce operations under the 340B Program, recommend areas for improvement and help to prepare for future program integrity audits.
